Source - RNS
RNS Number : 0991K
Microsaic Systems plc
16 September 2016
 

16 September 2016

 

Microsaic Systems plc

 

("Microsaic", "Microsaic Systems" or the "Company")

 

Change of registered holding of Director's shares

 

Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that Colin Nicholl, non-executive Chairman of the Company, has transferred 500,000 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares") from the Company's employee share dealing account at N+1 Singer to his account at Schroder & Co. Limited.

 

There has been no change to Mr Nicholl's beneficial interest in the Company which remains at 4,303,559 Ordinary Shares, representing 2.4% of the issued share capital and total voting rights of the Company.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides additional detail.

 

Enquiries:


Microsaic Systems plc

Jim Ramage, CEO

Bevan Metcalf, FD

+44 (0) 1483 751577

 

N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson

Liz Yong

 

 

+44 (0)20 7496 3000

Citigate Dewe Rogerson (Financial PR)

Mark Swallow, Marine Perrier

+44 (0)20 7282 2948/1068

 

About Microsaic Systems

 

Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D.  MS is an analytical technique of choice for biochemists across many industry sectors.

 

Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.

 

The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.

 

The Microsaic 4000 MiD®, single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).

 

www.microsaic.com  

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 C J Nicholl

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR - Non-executive Chairman

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Microsaic Systems plc

b)

 

LEI

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 0.25p each

 

GB00B547ZY09

 

b)

 

Nature of the transaction

 

Transfer of ordinary shares between accounts of the PDMR

 

No change in beneficial ownership

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

500,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

Not applicable

 

 

e)

 

Date of the transaction

 

15 September 2016

f)

 

Place of the transaction

 

Outside of trading venue

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSFEFEMFMSELU